Business Description
AIM ImmunoTech Inc
NAICS : 325414
SIC : 2836
ISIN : US42366C3016
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | -0.12 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -41.77 | |||||
Beneish M-Score | -5.64 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.2 | |||||
3-Year EBITDA Growth Rate | -16.9 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | -9.4 | |||||
3-Year Book Growth Rate | -48.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 213.09 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.9 | |||||
9-Day RSI | 33.66 | |||||
14-Day RSI | 38.51 | |||||
6-1 Month Momentum % | -37.42 | |||||
12-1 Month Momentum % | -63.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 1.14 | |||||
Days Sales Outstanding | 1116.19 | |||||
Days Payable | 29456.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.2 | |||||
Shareholder Yield % | -13.84 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.14 | |||||
Operating Margin % | -15715.92 | |||||
Net Margin % | -13952.74 | |||||
FCF Margin % | -11690.86 | |||||
ROE % | -189.75 | |||||
ROA % | -124.35 | |||||
ROIC % | -510.37 | |||||
3-Year ROIIC % | 87.57 | |||||
ROC (Joel Greenblatt) % | -3435.16 | |||||
ROCE % | -190.01 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 77.48 | |||||
PB Ratio | 2.9 | |||||
Price-to-Tangible-Book | 4.48 | |||||
EV-to-EBIT | -0.35 | |||||
EV-to-EBITDA | -0.36 | |||||
EV-to-Revenue | 51.98 | |||||
EV-to-Forward-Revenue | 55.02 | |||||
EV-to-FCF | -0.47 | |||||
Price-to-Median-PS-Value | 0.5 | |||||
Price-to-Net-Current-Asset-Value | 22.4 | |||||
Price-to-Net-Cash | 22.4 | |||||
Earnings Yield (Greenblatt) % | -284.67 | |||||
FCF Yield % | -137.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
AIM ImmunoTech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.186 | ||
EPS (TTM) (€) | -0.526 | ||
Beta | 1.48 | ||
Volatility % | 58.19 | ||
14-Day RSI | 38.51 | ||
14-Day ATR (€) | 0.04643 | ||
20-Day SMA (€) | 0.2653 | ||
12-1 Month Momentum % | -63.89 | ||
52-Week Range (€) | 0.197 - 0.595 | ||
Shares Outstanding (Mil) | 57.14 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AIM ImmunoTech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AIM ImmunoTech Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
AIM ImmunoTech Inc Frequently Asked Questions
What is AIM ImmunoTech Inc(FRA:HXB2)'s stock price today?
When is next earnings date of AIM ImmunoTech Inc(FRA:HXB2)?
Does AIM ImmunoTech Inc(FRA:HXB2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |